Until now, little research had been conducted into the mortality rates of non-cystic fibrosis bronchiectasis patients. However, a study group at a Turkish hospital have looked into the variables concerned with survival and death rates of the disease.
In a bid to target bronchiectasis patients with more effective treatments, the study looked at different factors which could impact survival including the age of the patients, partial oxygen pressure, if they had any other existing health conditions, if they smoked, and if they had a pseudomonas aeruginosa infection.
The study looked at a total of 56 patients—29 women and 27 men—and collected data over an eight-year period. The research concluded that comorbidities, pseudomonas aeruginosa, age and partial oxygen pressure contributed to higher mortality rates, but surprisingly smoking, treatment regimes and vaccinations did not. Find out more about this study here.
Bronchiectasis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.